SAN JOSE: Menopausal women experiencing a decline in executive functions, including difficulty with time management, attention, organization, memory, and problem solving, may be helped with a drug already approved to treat attention-deficit/hyperactivity disorder (ADHD), new research suggests.
The double-blind, placebo-controlled study showed that menopausal women who took lisdexamfetamine showed improvement in both subjective and objective measures of cognitive decline that are often experienced at menopause…